107 results
Page 4 of 6
F-3
44y1 rovu7yu73b5uadm
16 Sep 19
Shelf registration (foreign)
4:52pm
F-1
t73jwpdygn9sm7ul
16 Sep 19
Registration statement (foreign)
4:32pm
6-K
EX-99.2
xm4z3ntj pdg3
8 Aug 19
Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update
4:32pm
20-F/A
EX-4.17
hx14eqgnj26l9kfnm
3 Apr 19
Annual report (foreign) (amended)
7:38am
6-K
EX-99.1
a29gl75 ac
22 Mar 19
Report of Foreign Private Issuer
4:30pm
424B5
q6g6qa3
18 Jan 19
Prospectus supplement for primary offering
12:03pm
6-K
EX-4.2
h0sc la8tqo6
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
EX-1.1
vgyh6 r5u
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
EX-4.1
lg14ybwl39xoq dt
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
EX-99.1
1n5yf5s1rmpn56salujj
19 Dec 18
Report of Foreign Private Issuer
4:39pm
6-K
EX-99.2
8l6bh
9 Nov 18
Notice of 2018 Annual General Meeting of Shareholders
4:35pm
6-K
EX-99.1
e7lbpe
11 Oct 18
Kitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial Officer
9:35am
6-K
EX-99.1
8a0 0ljvdjahekkt6k01
26 Sep 18
Kitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy Conference
10:42am
6-K
EX-99.1
1rn23g
19 Sep 18
Kitov Pharma Updates on Motions in USA Initiated by Kitov Chairman
4:16pm
F-3/A
v1ge42dstbdf33yf17
3 Aug 18
Shelf registration (foreign) (amended)
7:10am
F-3
nxq g3nr387lx1nvc2
16 Jul 18
Shelf registration (foreign)
5:24pm
6-K
EX-99.1
twpegz4n9o
27 Jun 18
Kitov to Host Business Update Conference Call on Monday, July 2
9:28am
6-K
si1h 540d7
18 Jun 18
Report of Foreign Private Issuer
6:13am